Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldebain vs PCEA for Post-Cesarean Pain
NCT05187520Phase 2Unknown
- Sponsor
- E-Da Hospital
- Start
- Sep 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dinalbuphine sebacate in postoperative pain, sponsored by E-Da Hospital. Status: unknown.
02
Drugs
dinalbuphine sebacate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05187520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05187520.